Novel non-indolic melatonin receptor agonists differentially entrain endogenous melatonin rhythm and increase its amplitude

European Journal of Pharmacology

Volumn 382, Issue 3, 1999, Pages 157-166

  Drijfhout, Willem J ^a   De Vries, Jan B ^a   Homan, Evert J ^a   Brons, Heleen F ^a   Copinga, Swier ^a   Gruppen, Gert ^a   Beresford, Isabel J M ^b   Hagan, Russell M ^b   Grol, Cor J ^a   Westerink, Ben H C ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Amplitude; Entrainment; Melatonin receptor agonist; Microdialysis; Pineal gland

Indexed keywords

2 ACETAMIDO 8 METHOXYTETRALIN; 2 CHLOROACETAMIDO 8 METHOXYTETRALIN; 4 METHOXY 2 (METHYLENEPROPAMIDE)INDAN; INDAN DERIVATIVE; INDOLE DERIVATIVE; MELATONIN; MELATONIN RECEPTOR; N [2 (2,3,7,8 TETRAHYDRO 1H FURO[2,3 G]INDOL 1 YL)ETHYL]ACETAMIDE; TETRALIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DARKNESS; HORMONE RELEASE; MALE; MICRODIALYSIS; NONHUMAN; PINEAL BODY; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIRCADIAN RHYTHM; INDANS; INDOLES; MALE; MELATONIN; MICRODIALYSIS; PINEAL GLAND; RATS; RATS, WISTAR; RECEPTORS, CELL SURFACE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, MELATONIN; TETRAHYDRONAPHTHALENES; TIME FACTORS;

EID: 0032753841     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00619-6     Document Type: Article

References (34)

1. Arendt J. Melatonin and the Mammalian Pineal Gland. 1995;Chapman & Hall, London.
2. Armstrong S.M. Melatonin and circadian control in mammals. Experientia. 45:1989;932-938.
3. Benes L., Claustrat B., Horriere F., Geoffriau M., Konsil J., Parrott K., DeGrande G., McQuinn R.L., Ayres J.W. Transmucosal, oral controlled-release, and transdermal drug administration in human subjects: a crossover study with melatonin. J. Pharm. Sci. 86:1997;1115-1119.
4. Beresford I.J.M., Starkey S.J., Oakley N.R., Stratton S.C., Hagen R.M. GR196429: a non-indolic agonist at high affinity melatonin receptors which mediate the actions of melatonin on the rat circadian clock. Br. J. Pharmacol. 120:1997;. 360 pp.
5. Beresford I.J., Browning C., Starkey S.J., Brown J., Foord S.M., Coughlan J., North P.C., Dubocovich M.L., Hagan R.M. GR196429: a nonindolic agonist at high-affinity melatonin receptors. J. Pharmacol. Exp. Ther. 285:1998;1239-1245.
6. Cassone V.M. Effects of melatonin on vertebrate circadian systems. Trends Neurosci. 13:1990;457-464.
7. Cassone V.M., Warren W.S., Brooks D.S., Lu J. Melatonin, the pineal gland, and circadian rhythms. J. Biol. Rhythms. 8:1993;S73-S81. Suppl.
8. Copinga S., Tepper P.G., Grol C.J., Horn A.S., Dubocovich M.L. 2-Amido-8-methoxytetralins: a series of nonindolic melatonin-like agents. J. Med. Chem. 36:1993;2891-2898.
9. Delgado M.J., Alonso Gomez A.L., Gancedo B., De Pedro N., Valenciano A.I., Alonso Bedate M. Serotonin N-acetyltransferase (NAT) activity and melatonin levels in the frog retina are not correlated during the seasonal cycle. Gen. Comp. Endocrinol. 92:1993;143-150.
10. Drijfhout W.J., Grol C.J., Westerink B.H. Microdialysis of melatonin in the rat pineal gland: methodology and pharmacological applications. J. Neurochem. 61:1993;936-942.
11. Drijfhout W.J., Homan E.J., Brons H.F., Oakley N.R., Skingle M., Grol C.J., Westerink B.H. Exogenous melatonin entrains rhythm and reduces amplitude of endogenous melatonin: an in vivo microdialysis study. J. Pineal Res. 20:1996;24-32.
12. Drijfhout W.J., van der Linde A.G., de Vries J.B., Grol C.J., Westerink B.H. Microdialysis reveals dynamics of coupling between noradrenaline release and melatonin secretion in conscious rats. Neurosci. Lett. 202:1996;185-188.
13. Drijfhout W.J., van der Linde A.G., Kooi S.E., Grol C.J., Westerink B.H. Norepinephrine release in the rat pineal gland: the input from the biological clock measured by in vivo microdialysis. J. Neurochem. 66:1996;748-755.
14. Dubocovich M.L. Melatonin is a potent modulator of dopamine release in the retina. Nature. 306:1983;782-784.
15. Dubocovich M.L. Melatonin receptors: are there multiple subtypes? Trends Pharmacol. Sci. 16:1995;50-56.
16. 1 presynaptic heteroreceptor. Naunyn-Schmiedeberg's Arch. Pharmacol. 355:1997;365-375.
17. Gruppen, G., Grol, C.J., 1995. Synthesis of new melatonin agonists. Perspectives in Receptor Research, Camerinio, Italy. Abstract 214.
18. Haimov I., Lavie P. Potential of melatonin replacement therapy in older patients with sleep disorders. Drugs Aging. 7:1995;75-78.
19. Kanematsu N., Honma S., Katsuno Y., Honma K. Immediate response to light of rat pineal melatonin rhythm: analysis by in vivo microdialysis. Am. J. Physiol. 266:1994;R1849-R1855.
20. Kaplan J.B., Berria M., Mead R.A. Prolactin levels in the western spotted skunk: changes during pre- and periimplantation and effects of melatonin and lesions to the anterior hypothalamus. Biol. Reprod. 44:1991;991-997.
21. Morgan P.J., Barrett P., Howell H.E., Helliwell R. Melatonin receptors: localization, molecular pharmacology and physiological significance. Neurochem. Int. 24:1994;101-146.
22. Nelson E., Panksepp J., Ikemoto S. The effects of melatonin on isolation distress in chickens. Pharmacol. Biochem. Behav. 49:1994;327-333.
23. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1982;Academic Press, Sydney, Australia.
24. Redman J., Armstrong S., Ng K.T. Free-running activity rhythms in the rat: entrainment by melatonin. Science. 219:1983;1089-1091.
25. Redman J.R., Guardiola Lemaitre B., Brown M., Delagrange P., Armstrong S. Dose dependent effects of S-20098, a melatonin agonist, on direction of re-entrainment of rat circadian activity rhythms. Psychopharmacology (Berlin). 118:1995;385-390.
26. 1b melatonin receptor. Proc. Natl. Acad. Sci. U.S.A. 92:1995;8734-8738.
27. Rozell M.D., Mead R.A. Effect of melatonin on pituitary secretion of prolactin in vitro during delayed implantation and the periimplantation period in the spotted skunk. J. Exp. Zool. 267:1993;524-532.
28. Stankov B., Fraschini F., Reiter R.J. Melatonin binding sites in the central nervous system. Brain Res. Brain Res. Rev. 16:1991;245-256.
29. Valcavi R., Zini M., Maestroni G.J., Conti A., Portioli I. Melatonin stimulates growth hormone secretion through pathways other than the growth hormone-releasing hormone. Clin. Endocrinol. (Oxford). 39:1993;193-199.
30. 2+ in neonatal rat pituitary cells. Endocrinology. 130:1992;701-707.
31. Warren W.S., Hodges D.B., Cassone V.M. Pinealectomized rats entrain and phase-shift to melatonin injections in a dose-dependent manner. J. Biol. Rhythms. 8:1993;233-245.
32. Wun W.S., Jackson F.L., Preslock J.P., Berkowitz A.S. Effect of melatonin in vivo upon FSH and LH release from hamster pituitary glands. Mol. Cell Endocrinol. 46:1986;227-234.
33. Yaga K., Reiter R.J., Richardson B.A. Tryptophan loading increases daytime serum melatonin levels in intact and pinealectomized rats. Life Sci. 52:1993;1231-1238.
34. Yasin S.A., Costa A., Besser G.M., Hucks D., Grossman A., Forsling M.L. Melatonin and its analogs inhibit the basal and stimulated release of hypothalamic vasopressin and oxytocin in vitro. Endocrinology. 132:1993;1329-1336.